Get access

Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures

Authors


  • Colour Online: See the article online to view Figs. 1–3 in colour.

Correspondence: Dr. Jake Y. Chen, School of Informatics, Indiana University, 719 N Indiana Ave, WK Suite 190, Indianapolis, IN 46202-3103, USA

E-mail: jakechen@iupui.edu

Abstract

The prediction of adverse drug reactions (ADRs) has become increasingly important, due to the rising concern on serious ADRs that can cause drugs to fail to reach or stay in the market. We proposed a framework for predicting ADR profiles by integrating protein–protein interaction (PPI) networks with drug structures. We compared ADR prediction performances over 18 ADR categories through four feature groups—only drug targets, drug targets with PPI networks, drug structures, and drug targets with PPI networks plus drug structures. The results showed that the integration of PPI networks and drug structures can significantly improve the ADR prediction performance. The median AUC values for the four groups were 0.59, 0.61, 0.65, and 0.70. We used the protein features in the best two models, “Cardiac disorders” (median-AUC: 0.82) and “Psychiatric disorders” (median-AUC: 0.76), to build ADR-specific PPI networks with literature supports. For validation, we examined 30 drugs withdrawn from the U.S. market to see if our approach can predict their ADR profiles and explain why they were withdrawn. Except for three drugs having ADRs in the categories we did not predict, 25 out of 27 withdrawn drugs (92.6%) having severe ADRs were successfully predicted by our approach.

Ancillary